Josh Andersen

Josh Andersen is an Associate Professor of Oncological Sciences at the University of Utah, with affiliations to the Molecular Biology Program and Biological Chemistry Program. His research focuses on cancer cell signaling, molecular mechanisms, kinase regulation, autophagy, and cell survival.

Education:

• B.S., Brigham Young University
• Ph.D., University of Utah

Research Interests:

Dr. Andersen's lab combines molecular and biochemical approaches with proteomics to uncover mechanisms that control tumor cell growth and survival. His work emphasizes understanding post-translational modifications (PTMs) and their roles in cancer biology, particularly through the study of 14-3-3 proteins, understudied kinases, and autophagy regulation.

Key Research Areas:

• Decoding cell signaling through dynamic PTMs
• Harnessing 14-3-3 proteins as proteomics probes for tumor biology
• Investigating understudied kinases like TNK1 and ACK1
• Elucidating basal autophagy mechanisms in cancer
• Developing computational tools for PTM analysis

Scientific Contributions:

Dr. Andersen has published extensively on kinase regulation, autophagy, and cancer signaling, with recent work in Nature Communications and EMBO Reports. His lab's findings have implications for targeted cancer therapies and understanding tumor vulnerabilities.

Lab and Collaborations:

His lab is part of the Huntsman Cancer Institute (HCI) at the University of Utah, fostering interdisciplinary collaborations in cancer research. The lab's website and PubMed literature search are available for further exploration.